Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural Mesothelioma

Ruchika Sharma1 Jun 2024 12:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...

Sun Pharma Gets CDSCO Panel Nod for Phase IV Trial of Esomeprazole Dual Release Tablets 80 mg

Results of Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024

Ruchika Sharma1 Jun 2024 11:30 AM IST

Mumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced that the primary results of the Nidlegy Phase III PIVOTAL...

Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapy

USFDA requests additional data on Sanofi Dupixent for treating smoker's lung

Ruchika Sharma31 May 2024 3:16 PM IST

Paris: Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) requested additional efficacy analyses on the efficacy...

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

Bristol Myers Squibb Breyanzi gets USFDA nod for Relapsed or Refractory Mantle Cell Lymphoma

Ruchika Sharma31 May 2024 2:15 PM IST

Princeton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted approval for Breyanzi (lisocabtagene...

Granules recalls over 33000 bottles BP medication in US

Dr Reddy's Labs, Sun Pharma recall products in American market over manufacturing issues

Ruchika Sharma31 May 2024 12:11 PM IST

New Delhi: Dr Reddy's Laboratories and Sun Pharma are recalling products in the American market following manufacturing concerns, as stated by...

Migraine drug: Natco Pharma submits application for generic version of Rimegepant Sulfate tablet with USFDA

Ruchika Sharma31 May 2024 11:00 AM IST

Telangana: Natco Pharma Limited has announced the submission of an Abbreviated New Drug Application (ANDA) containing a paragraph IV...

Apollo Ahmedabad Reinforces Commitment to Quality with Fourth JCI Accreditation

Indian hospital chain operator Apollo Hospitals misses Q4 profit estimates

Ruchika Sharma31 May 2024 10:00 AM IST

Bengaluru: Apollo Hospitals, a hospital chain operator in India, has reported a slight miss in fourth-quarter profit estimates. Despite revenue...

India targets new markets for pharma export growth amid US tariffs concerns

Indian pharma export sales to see faster growth this year: Trade body

Ruchika Sharma30 May 2024 5:50 PM IST

Hyderabad: India's pharmaceutical export sales are projected to accelerate to nearly 11% this fiscal year, up from a roughly 10% rise last year,...

Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan

Alembic Pharma gets USFDA nod for Sacubitril and Valsartan Tablets for heart failure

Ruchika Sharma30 May 2024 4:27 PM IST

Vadodara: Alembic Pharmaceuticals Limited has announced that the Company has received final approval from the US Food & Drug Administration...

Alkem Labs net profit soars four-fold to Rs 293 crore in Q4

Ruchika Sharma30 May 2024 2:30 PM IST

Alkem Laboratories has announced that its consolidated net profit soared four-fold to Rs 293 crore for the March 2024 quarter, compared to a net...

Bristol Myers Squibb gets European Commission nod for Opdivo in combo with cisplatin, gemcitabine for urothelial carcinoma

Ruchika Sharma30 May 2024 12:49 PM IST

Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with...

Dr Reddy's Labs names Milan Kalawadia as CEO, North America

Ruchika Sharma30 May 2024 11:30 AM IST

Hyderabad: Dr. Reddy's Laboratories Ltd., has announced the appointment of Milan Kalawadia as Chief Executive Officer, North America, and member...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok